Peril and Promise: The Present and Future of Kidney Transplantation
Submission Deadline: November 30, 2018 (Open) Submit Now
Steven Potter, MD, FACS
Transplant Program Director, Chair of Division of Transplantation, East Texas Medical Center, 1100 E. Lake St., Ste. 340, Tyler, TX 75701, USA
E-Mail: [email protected]
Research Interests: renal transplantation; pancreas transplantation; living kidney donation; transplant immunosuppression; urology; urologic oncology
About This Topic
Renal transplantation is the gold standard therapy for treatment of end stage renal failure. However, the supply of living and deceased donor kidneys continues to be inadequate to meet demand. Long-term outcomes after renal transplantation improved dramatically for years, but have been relatively stable for the last decade. This special edition is open to submissions regarding existing and potential mechanisms to improve access to, and outcomes after, renal transplantation. Manuscripts are sought that address deceased donor kidney allocation, selection, and preservation, efforts to increase the utilization of high-risk organs, current and potential changes to the allocation system and regulatory environment, xenotransplantation, stem cell therapy, and novel immunosuppression approaches likely to impact outcomes and access to transplantation. We also seek manuscripts evaluating or proposing mechanisms to increase living donation via paired and chain donation, as well as ABO incompatible and crossmatch positive living donor transplants.